A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Titel:
A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Auteur:
Chung, C.H. Lee, J.W. Slebos, R.J. Howard, J.D. Perez, J. Kang, H. Fertig, E.J. Considine, M. Gilbert, J. Murphy, B.A. Nallur, S. Paranjape, T. Jordan, R.C. Garcia, J. Burtness, B. Forastiere, A.A. Weidhaas, J.B.